Steven Cohen Relay Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 13,445,704 shares of RLAY stock, worth $45 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
13,445,704
Previous 10,827,067
24.19%
Holding current value
$45 Million
Previous $28.4 Million
64.01%
% of portfolio
0.1%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding RLAY
# of Institutions
213Shares Held
172MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$93.5 Million0.77% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$44.7 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$38.2 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$35.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$31.4 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $403M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...